How can we accelerate successful drug discovery and development?

The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.


Join us on Thursday, June 14, 2018 at Farmer & the Seahorse 10996 Torreyana Rd, San Diego, CA 92121 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.


11:30 AM- 12:30 PM

Registration & Lunch, Opening Remarks

12:30 PM- 4:50 PM


4:50 PM- 5:00 PM

Closing Remarks

5:00 PM- 6:00 PM

Networking Reception and Happy Hour



Why Bother? Impact of Downstream Development and Market Considerations on Discovery Projects

Vince Wacher, Ph. D. | Product Development and Planning


The ReFRAME Drug Repositioning Library: Building and Applications to Neglected Diseases

Arnab Chatterjee, Ph. D. | VP Medicinal Chemistry | Calibr


Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models

Tommy Broudy, Ph. D. | CEO | Molecular Response


BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development

Blair West, Ph. D. | CSO, Global CMC Solutions | BioDuro


Development of Poorly Soluble Compounds: Discovery to FIH and Later Clinical Development Phases

Hamid Rezai, Ph. D. | Senior Director of Pharmaceutics | Plexxikon Inc.


Reactive Melt Extrusion to Improve Properties of Amorphous Solid Dispersions

Feng Zhang, Ph. D. | Assistant Professor of Pharmaceutics | University of Texas at Austin


Registeration link: